norfloxacin has been researched along with Chancroid in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Chancroid: Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
Excerpt | Relevance | Reference |
---|---|---|
"Forty-one men with a clinically and bacteriologically verified diagnosis of chancroid were given a single dose of 800 mg of norfloxacin and were examined clinically and bacteriologically four, seven and 14 days after treatment." | 9.06 | Clinical and microbiological efficacy of a single dose of norfloxacin in the treatment of chancroid. ( Ariyarit, C; Buatiang, A; Chitwarakorn, A; Kuvanont, K; Mokamukkul, B; Singharaj, P; Wongba, C, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ariyarit, C | 1 |
Mokamukkul, B | 1 |
Chitwarakorn, A | 1 |
Wongba, C | 1 |
Buatiang, A | 1 |
Singharaj, P | 1 |
Kuvanont, K | 1 |
1 trial available for norfloxacin and Chancroid
Article | Year |
---|---|
Clinical and microbiological efficacy of a single dose of norfloxacin in the treatment of chancroid.
Topics: Administration, Oral; Adolescent; Adult; Chancroid; Clinical Trials as Topic; Drug Administration Sc | 1988 |